EL
ELV
Year ended Dec 31, 2025 · FY2025 10-K

Elevance Health (ELV) 10-K Summaries & Annual Filing History

Review Elevance Health, Inc. (ELV) 10-K filings from 2023 through the latest annual report, including business, financial performance, risks, and liquidity.

Key takeaway

Year ended Dec 31, 2025 · FY2025 10-K

Elevance Health filed its annual 10-K report, detailing financial results for its most recent fiscal year. The filing includes business overview, risk factors, management discussion and analysis, and liquidity and capital resources sections.

Financial snapshot

Selected annual figures reported with the filing, shown separately from the narrative summary.

Annual revenue

$199.1B

Revenue reported for the fiscal year.

Operating income

$7.2B

Income from operations reported for the year.

Net income

$5.7B

Net income reported for the year.

Operating cash flow

$4.3B

Cash generated by operating activities.

Annual revenue trend

Reported annual revenue and its change from the preceding fiscal year.

Period endedRevenueYear-over-year change
Dec 31, 2022$156.6B+13.0%
Dec 31, 2023$171.3B+9.4%
Dec 31, 2024$177B+3.3%
Dec 31, 2025$199.1B+12.5%

Business overview

The company operates as a health benefits provider, serving members through various health plans. Its business is subject to regulatory and competitive factors as outlined in the filing.

Financial performance

Revenue grew compared to the prior year, supported by business operations. Operating income and net income also increased, while operating cash flow provided a source of funds.

Material risks

The company faces risks from healthcare regulation changes, competitive pressures, and cybersecurity threats. These factors could affect business results and are discussed in the risk factors section.

Liquidity and capital

The filing describes capital resources and liquidity positions, indicating the company maintains access to funds for operations and investments.

What to watch

Readers should monitor any changes in healthcare legislation that could materially impact the company's business model.